Limited data exist about the use of insulin degludec and insulin glargine U300 in the
hospitalized patients. A previous study compared the safety and efficacy of insulin degludec
versus insulin glargine U100 for the management of hospitalized patients with type 2
diabetes. However, there is no data comparing the efficacy and safety of insulin degludec
versus insulin glargine U300 for the management of hospitalized patients with type 2
diabetes. Accordingly, the proposed study will provide a clinically useful information on the
efficacy (blood glucose control) and safety (hypoglycemia) of insulin degludec versus insulin
glargine U300 for the management of hospitalized patients with type 2 diabetes.